v3.21.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Jun. 30, 2021
Dec. 31, 2020
Current assets:    
Cash $ 13,386,332 $ 1,858,513
Account receivable, net of allowance of $5,470,897 and $257,463 as of June 30, 2021 and December 31, 2020, respectively   831,390
Prepaid expenses and other current assets 5,147,650 240,352
Total current assets 18,533,982 2,930,255
Other assets 12,730 10,914
Total assets 18,546,712 2,941,169
Current liabilities:    
Accounts payable (includes $44,201 and $149,067 due to related parties) 6,268,319 3,153,310
Accrued and other current liabilities 1,506,337 1,728,483
Accrued clinical site costs 1,133,312 1,547,432
Earnout Cash liability 25,874,896  
Warrant liabilities 515,025  
Notes payable and accrued interest 173,694 248,861
Accrued settlement expense   39,486,139
Total current liabilities 35,471,583 46,164,225
Notes payable and accrued interest 512,472 547,827
Total liabilities 35,984,055 46,712,052
Stockholders' equity (deficit):    
Preferred stock, $0.001 par value, 50,000,000 shares authorized; 0 shares issued and outstanding at June 30, 2021 and December 31, 2020, respectively
Common stock, $0.001 par value, 500,000,000 shares authorized; 48,603,585 and 42,973,462 shares issued and outstanding at June 30, 2021 and December 31, 2020, respectively 48,604 42,974
Additional paid-in capital 114,190,620 46,365,863
Accumulated deficit (131,676,567) (90,179,720)
Total stockholders' equity (deficit) (17,437,343) (43,770,883)
Total liabilities and stockholders' equity (deficit) $ 18,546,712 $ 2,941,169

Source